Table 4.
Anticoagulation and bleeding complications
| Patient number | Anticoagulation | APTT meana (SD) | Bleeding site | Maternal outcome |
|---|---|---|---|---|
| 1 | Heparin | 76 (23) | Nil | Survived |
| 2 | Heparin | 61 (22) | Nil | Survived |
| 3 | Heparin | 112 (37) | Nil | Survived |
| 4 | Heparin | 152 (66) | Uterine | Survived |
| 5 | Heparin | 152 (59) | Pulmonary | Survived |
| 6 | Heparin | N/A | Multiple | Died |
| 7 | Heparin | 70 (12) | Intracranial | Died |
| 8 | Heparin | 69 (12) | ECMO cannula | Died |
| 9 | Heparin | 95 (66) | Nil | Survived |
| 10 | Heparin | 54 (19) | Pulmonary | Died |
| 11 | Heparin | 72 (14) | ECMO cannula | Survived |
| 12 | Heparin | 76 (8) | Fasciotomy | Survived |
APPT activated partial thromboplastin time, SD standard deviation, N/A not available
aMean of highest daily APTT value (in seconds) achieved during ECMO therapy